Increase/Decrease in Cash: The total change in cash for the company over the given period.
FibroGen, Inc (FGEN) had Increase/Decrease in Cash of $-11.51M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$29.62M |
|
$-47.58M |
|
$15.56M |
|
$14.06M |
|
$180.04M |
|
$-150.42M |
|
$-2.95M |
|
$-153.37M |
|
$-153.37M |
|
$-153.10M |
|
$-153.10M |
|
$-47.58M |
|
$-153.10M |
|
$-150.42M |
|
$-149.40M |
|
100.04M |
|
100.04M |
|
$-0.48 |
|
$-0.48 |
|
| Balance Sheet Financials | |
$196.51M |
|
-- |
|
$18.02M |
|
$214.53M |
|
$133.31M |
|
$73.09M |
|
$286.33M |
|
$419.64M |
|
$-205.12M |
|
$-205.12M |
|
$-205.12M |
|
100.92M |
|
| Cash Flow Statement Financials | |
$-138.00M |
|
$125.99M |
|
$-0.26M |
|
$113.69M |
|
$102.18M |
|
|
Increase/Decrease in Cash |
$-11.51M |
$25.21M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.47 |
|
-- |
|
-- |
|
-0.55 |
|
-0.36 |
|
47.47% |
|
-507.80% |
|
-507.80% |
|
-504.39% |
|
-517.76% |
|
-160.63% |
|
$-137.22M |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
4.93 |
|
61.58 |
|
5.93 |
|
74.64% |
|
74.64% |
|
-71.37% |
|
115.96% |
|
$-2.03 |
|
$-1.37 |
|
$-1.38 |
|